Qingdao NovelBeam Technology Co (SHSE:688677) ROCE % : 13.84% (As of Mar. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Qingdao NovelBeam Technology Co ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Qingdao NovelBeam Technology Co's annualized ROCE % for the quarter that ended in Mar. 2024 was 13.84%.

Qingdao NovelBeam Technology Co ROCE % Historical Data

The historical data trend for Qingdao NovelBeam Technology Co's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Qingdao NovelBeam Technology Co ROCE % Chart

Qingdao NovelBeam Technology Co Annual Data

Trend

Dec13

Dec14

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROCE %

Get a 7-Day Free Trial

35.77

39.23

18.39

17.59

12.68

Qingdao NovelBeam Technology Co Quarterly Data
	Dec18	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
ROCE %	Get a 7-Day Free Trial															17.79	14.29	9.89	8.35	13.84

Qingdao NovelBeam Technology Co ROCE % Calculation

Qingdao NovelBeam Technology Co's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	160.707	/	( ( (1393.535 - 167.268)	+	(1394.843 - 85.408) )	/ 2 )
	=	160.707	/	( (1226.267	+	1309.435)	/ 2 )
	=	160.707	/	1267.851
	=	12.68 %

Qingdao NovelBeam Technology Co's ROCE % of for the quarter that ended in Mar. 2024 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Mar. 2024 )		(Q: Dec. 2023 )		(Q: Mar. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Mar. 2024 )		(Q: Dec. 2023 )		(Q: Mar. 2024 )
	=	183.388	/	( ( (1394.843 - 85.408)	+	(1398.284 - 58.188) )	/ 2 )
	=	183.388	/	( ( 1309.435	+	1340.096 )	/ 2 )
	=	183.388	/	1324.7655
	=	13.84 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2024) EBIT data.

Qingdao NovelBeam Technology Co (SHSE:688677) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Qingdao NovelBeam Technology Co ROCE % Related Terms

Thank you for viewing the detailed overview of Qingdao NovelBeam Technology Co's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Qingdao NovelBeam Technology Co (SHSE:688677) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Qingdao NovelBeam Technology Co Ltd (SHSE:688677) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 100, Weisi Road, Keyuan, Laoshan District, Shandong Province, Qingdao, CHN, 266100

Website

http://www.novelbeam.com

Qingdao NovelBeam Technology Co Ltd is engaged in the research and development, production and sales of medical endoscope equipment and optical products. The product portfolio of the group includes Endoscope, Camera coupler, Camera lens, Medical optics, Biometrics and others.

Executives

Wang Fang Hua	senior management
Mao Rong Zhuang	Core technical personnel
Zheng Jin Lan	Supervisors

Qingdao NovelBeam Technology Co (SHSE:688677) Headlines

No Headlines